New device is the only commercially available bedside monitor designed for home care and sleep study settings DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval ...
BOULDER, Colo.--(BUSINESS WIRE)--Every year, nearly 7,200 infants are born in the United States with a Critical Congenital Heart Disease (CCHD). 1 It is a condition that is often easily detectable and ...
- Nellcor™ Pulse Oximetry Technology Demonstrated Statistically Significant Difference in Time to Deliver a Stable Oxygen Saturation Value and Heart Rate According to the study, a stable signal was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results